Chronic myeloid leukemia (CML) is a rare condition during reproductive age. Still,
women may present with pre-existing or newly diagnosed CML during
pregnancy. The management of
chronic myeloid leukemia during
pregnancy requires balancing the well-being of the
mother with that of
fetus.
Tyrosine Kinase inhibitors are considered the most effective
drug against CML but they are still not considered safe during
pregnancy and
breast feeding. So, there is a need for management of CML with alternate
drugs during
pregnancy. Here we
report a case of a 26-year-old lady
who was diagnosed with
chronic myelogenous leukemia (CML) at 20 weeks of
gestation and had an atypical
chromosome translocation t (922). She was managed jointly by
obstetrician and haemato-
oncologist for the remainder of her
pregnancy and eventually she delivered a healthy baby at term.